Stockscreener 앱 받기
0.1647
10.73%
-0.0198
시간 외 거래:
.17
0.0053
+3.22%
전일 마감가:
$0.1845
열려 있는:
$0.1831
하루 거래량:
3.78M
Relative Volume:
1.59
시가총액:
$10.55M
수익:
-
순이익/손실:
$-123.46M
주가수익비율:
-0.0636
EPS:
-2.59
순현금흐름:
$-104.11M
1주 성능:
-13.36%
1개월 성능:
-47.66%
6개월 성능:
-55.50%
1년 성능:
-60.77%
1일 변동 폭
$0.1485
$0.1899
1주일 범위
$0.1485
$0.2238
52주 변동 폭
$0.14
$1.43
바이오아틀라 Stock (BCAB) Company Profile
명칭
Bioatla Inc
전화
858-558-0708
주소
11085 TORREYANA ROAD, SAN DIEGO
Compare BCAB vs VRTX, REGN, ARGX, ALNY, ONC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
BCAB
Bioatla Inc
|
0.1647 | 11.82M | 0 | -123.46M | -104.11M | -2.59 |
|
VRTX
Vertex Pharmaceuticals Inc
|
465.02 | 117.03B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
783.65 | 82.35B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
833.54 | 51.64B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
308.48 | 42.58B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
346.42 | 38.87B | 4.98B | 69.60M | 525.67M | 0.5198 |
바이오아틀라 Stock (BCAB) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-01-13 | 개시 | Rodman & Renshaw | Buy |
| 2025-08-13 | 다운그레이드 | Citizens JMP | Mkt Outperform → Mkt Perform |
| 2024-11-13 | 다운그레이드 | H.C. Wainwright | Buy → Neutral |
| 2022-09-15 | 개시 | JMP Securities | Mkt Outperform |
| 2022-05-05 | 다운그레이드 | Credit Suisse | Outperform → Neutral |
| 2022-03-21 | 개시 | H.C. Wainwright | Buy |
| 2021-10-15 | 재개 | BTIG Research | Buy |
| 2021-06-28 | 개시 | ROTH Capital | Buy |
| 2021-05-05 | 재개 | Credit Suisse | Outperform |
| 2021-04-26 | 재개 | Credit Suisse | Outperform |
| 2021-01-11 | 개시 | BTIG Research | Buy |
| 2021-01-11 | 개시 | Credit Suisse | Outperform |
| 2021-01-11 | 개시 | JP Morgan | Overweight |
| 2021-01-11 | 개시 | Jefferies | Buy |
모두보기
바이오아틀라 주식(BCAB)의 최신 뉴스
12 Health Care Stocks Moving In Thursday's After-Market Session - Benzinga
BioAtla Sets March Virtual Vote on Internal Merger Plan - TipRanks
BioAtla (BCAB) seeks approval for 1‑for‑50 share conversion to support Nasdaq listing - Stock Titan
Bioatla Faces Nasdaq Delisting Review Amid Corporate Restructuring - AD HOC NEWS
Is BioAtla Inc. currently under institutional pressureQuarterly Risk Review & Technical Analysis for Trade Confirmation - mfd.ru
BioAtla to remain on Nasdaq during listing council review process By Investing.com - Investing.com India
BioAtla to remain on Nasdaq during listing council review process - Investing.com
BioAtla Faces Nasdaq Review of Continued Listing Status - TipRanks
BioAtla Faces Nasdaq Delisting Review - TradingView
Why STMicroelectronics Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket - Benzinga
BioAtla to be suspended from Nasdaq after delisting determination By Investing.com - Investing.com Nigeria
BioAtla to be suspended from Nasdaq after delisting determination - Investing.com
BioAtla Faces Nasdaq Trading Suspension and Potential Delisting - TipRanks
BioAtla Received Notice of Delisting - TradingView
Activity Recap: Will BioAtla Inc benefit from AI trends2025 Biggest Moves & Precise Buy Zone Tips - baoquankhu1.vn
BioAtla sets merger plan after Nasdaq rule change affects reverse split vote By Investing.com - Investing.com South Africa
BioAtla sets merger plan after Nasdaq rule change affects reverse split vote - Investing.com Australia
BioAtla (BCAB) seeks approval for 1-for-50 share conversion and charter changes - stocktitan.net
BioAtla Pursues Share Consolidation Amid Nasdaq Compliance Dispute - TipRanks
Street Watch: What is the dividend yield of BioAtla IncGold Moves & Reliable Momentum Entry Alerts - baoquankhu1.vn
Is BioAtla Inc. a turnaround story2025 Biggest Moves & Verified Technical Trade Signals - mfd.ru
EPS Watch: Will BioAtla Inc stock hit new highs in YEARWeekly Profit Report & Smart Investment Allocation Tips - baoquankhu1.vn
12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga
Aug Mood: Will BioAtla Inc stock hit new highs in YEAR2025 Earnings Impact & Real-Time Volume Analysis - baoquankhu1.vn
Aug Sectors: Is BioAtla Inc forming bullish engulfing patternsJuly 2025 Outlook & Weekly Chart Analysis and Guides - baoquankhu1.vn
Aug Chart Watch: What is the dividend yield of BioAtla IncWatch List & Technical Buy Zone Confirmations - baoquankhu1.vn
Whale Trades: Is BioAtla Inc forming bullish engulfing patternsJuly 2025 Price Swings & Risk Controlled Daily Plans - baoquankhu1.vn
What analysts say about BioAtla Inc. stockTrade Risk Assessment & Free Low Drawdown Momentum Trade Ideas - bollywoodhelpline.com
BioAtla stock slips premarket after early pop as investors weigh $40M SPV deal for phase 3 cancer trial - MSN
Aug Decliners: Can BioAtla Inc deliver consistent dividendsEarnings Overview Summary & Scalable Portfolio Growth Methods - baoquankhu1.vn
Big Money Moves: Should you buy the dip on BioAtla IncJuly 2025 Update & High Accuracy Trade Signal Alerts - baoquankhu1.vn
Brokerages Set BioAtla, Inc. (NASDAQ:BCAB) Target Price at $4.00 - Defense World
BioAtla faces Nasdaq delisting over share price rule - MSN
BioAtla (NASDAQ:BCAB) Coverage Initiated by Analysts at Rodman & Renshaw - Defense World
VIX Spike: Can BioAtla Inc deliver consistent dividendsJuly 2025 Review & Precise Entry and Exit Recommendations - baoquankhu1.vn
BioAtla Creates Super-Voting Share to Advance Reverse Split - The Globe and Mail
BioAtla stock initiated with Buy rating at Rodman & Renshaw - Investing.com
BioAtla stock initiated with Buy rating at Rodman & Renshaw By Investing.com - Investing.com India
Why BioAtla Inc. stock remains resilientJuly 2025 Gainers & Real-Time Buy Signal Notifications - Улправда
BioAtla, Inc.Common Stock (NQ: BCAB - FinancialContent
Is BioAtla Inc. stock undervalued vs historical averages2025 Big Picture & Consistent Growth Stock Picks - ulpravda.ru
Is BioAtla Inc. stock attractive for hedge funds2025 Volatility Report & Daily Stock Trend Reports - Улправда
Is BioAtla Inc. stock dividend yield sustainable2025 Stock Rankings & Entry Point Confirmation Alerts - Улправда
What risks investors should watch in BioAtla Inc. stockEarnings Risk Report & Fast Entry Momentum Trade Alerts - Улправда
How BioAtla Inc. stock performs in rising dollar environmentMarket Volume Summary & Short-Term Trading Alerts - Улправда
How rising interest rates impact BioAtla Inc. stock2025 EndofYear Setup & Free Community Consensus Stock Picks - ulpravda.ru
Will BioAtla Inc. stock maintain momentum in 2025Volatility Index Analysis & Low Cost Portfolio Growth - ulpravda.ru
After-Hours Biotech Rally: Alumis, Genelux, Bright Minds, Context Therapeutics Post Big Gains - RTTNews
Why GH Research Shares Are Trading Higher By 18%; Here Are 20 Stocks Moving Premarket - Benzinga
BioAtla, GATC Health Advance Ozuriftamab Vedotin Into Phase 3 OPSCC Trial Via SPV Deal - Voice Of HealthCare
BioAtla Stock Slips Premarket After Early Pop As Investors Weigh $40M SPV Deal For Phase 3 Cancer Trial - Asianet Newsable
바이오아틀라 (BCAB) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.24%
0.19%
자본화:
|
볼륨(24시간):